Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021

Pragya D. Yadav,Rima R. Sahay,Sachee Agrawal,Anita Shete,Balkrishna Adsul,Srikanth Tripathy,Dimpal A. Nyayanit,Manish Manrai,Deepak Y. Patil, Sanjay Kumar,Vikas Marwah,Gajanan N. Sapkal,Jayanthi Shastri,Rajlakshmi Viswanathan,Priyanka Pandit,Yogendra Mishra,Smita Chavan,Yash Joshi, T. Ajai Kumar,Triparna Majumdar, Abhinendra Kumar, Savita Patil, Renuka Munshi, Unnati Desai, Himanshu Kaushal, Annasaheb Suryawanshi, Manisha Dudhmal, Pranita Gawande, Rajlaxmi Jain, Ashwini Waghmare, Kaumudi Kalele, Pratiksha Vedpathak, Jyoti Yemul, Poonam Bodke, Tejashri Kore, A. L. Kakrani, Prachi Athavale, Poonam Suryawanshi, Sudhir Patsute, Vikram Padbidri, Pradip Awate, Priya Abraham

Journal of Infection（2022）

引用 0|浏览5

暂无评分

摘要

•Globally breakthrough infections have occurred post COVID-19 vaccinations.•Delta and delta derivatives predominated amongst the infected cases.•All the cases presented with mild disease and had very low mortality.•Covishield and Covaxin vaccination could able to prevent the severe disease.•Assessment of immune response demonstrated need for booster dose.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要